Improved web-based calculators for predicting breast carcinoma outcomes
暂无分享,去创建一个
Jerry Younger | James S. Michaelson | Devon Bush | Barbara L. Smith | J. Michaelson | J. Younger | L. Leon Chen | Allan Fong | Barbara Smith | L. L. Chen | Allan Fong | D. Bush
[1] Karen A Gelmon,et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Kevin Hughes,et al. Predicting the survival of patients with breast carcinoma using tumor size , 2002, Cancer.
[3] 青儀 健二郎,et al. What's going on 乳癌 Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group(EBCTCG). Lancet. 2005; 365: 1687-717. PMID: 15894097.--早期乳癌に対する化学療法・内分泌療法が乳癌再発・15年生存率に及 , 2006 .
[4] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.
[5] Barbara L. Smith,et al. Why cancer at the primary site and in the lymph nodes contributes to the risk of cancer death , 2009, Cancer.
[6] Haesook T. Kim. Cumulative Incidence in Competing Risks Data and Competing Risks Regression Analysis , 2007, Clinical Cancer Research.
[7] Early Breast Cancer Trialists' Collaborative Group. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials , 2008, The Lancet.
[8] Mikael Lundin,et al. A web-based system for individualised survival estimation in breast cancer , 2003, BMJ : British Medical Journal.
[9] S. Singletary,et al. Breast Cancer Staging: Working With the Sixth Edition of the AJCC Cancer Staging Manual , 2006, CA: a cancer journal for clinicians.
[10] W. Al-Delaimy,et al. A hospital-based retrospective cohort study of allergen immunotherapy as a preventive treatment for new onset asthma , 2005 .
[11] E. Feuer,et al. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. , 2002, Journal of the National Cancer Institute.
[12] Barbara L. Smith,et al. Mammographic screening: Patterns of use and estimated impact on breast carcinoma survival , 2004, Cancer.
[13] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[14] R. Gray,et al. Efficacy of radiotherapy for ovarian ablation , 2004, Cancer.
[15] D J Ferguson,et al. Dormancy of mammary carcinoma after mastectomy. , 1999, Journal of the National Cancer Institute.
[16] D B Kopans,et al. Breast cancer: computer simulation method for estimating optimal intervals for screening. , 1999, Radiology.
[17] S. Mook,et al. Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study. , 2009, The Lancet. Oncology.
[18] Barbara L. Smith,et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. , 2004, The New England journal of medicine.
[19] P. Ravdin,et al. Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[20] J. Michaelson. Mammographic Screening: Impact on Survival , 2008 .
[21] James S. Michaelson. Using Information on Breast Cancer Growth, Spread, and Detectability to Find the Most Effective Ways for Screening to Reduce Breast Cancer Death , 2001 .
[22] Karen R. Sepucha,et al. Sensitivity to input variability of the Adjuvant! Online breast cancer prognostic model. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] Barbara L. Smith,et al. The non-breast-cancer death rate among breast cancer patients , 2011, Breast Cancer Research and Treatment.
[24] Catherine Legrand. 1687Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials : Early Breast Cancer Trialists' Collaborative Group (EBCTCG) , 2005 .
[25] Melania Pintilie,et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. , 2004, The New England journal of medicine.
[26] R. Peto,et al. Adjuvant chemotherapy in oestrogen-receptor-poor breast cancer: patient-level meta-analysis of randomised trials. , 2008, Lancet.
[27] Barbara L. Smith,et al. The impact of primary tumor size, lymph node status, and other prognostic factors on the risk of cancer death , 2009, Cancer.
[28] E. Arias,et al. United States life tables, 2005. , 2010, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[29] Donald A. Berry,et al. Estrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer , 2006 .
[30] Gary J Whitman,et al. Breast cancer staging. , 2006, Seminars in roentgenology.